Advertisement

Neurotherapeutics

, Volume 6, Issue 2, pp 415–420 | Cite as

Botanicals and herbs: A traditional approach to treating epilepsy

  • Steven C. SchachterEmail author
Theme 5: Hormonal and Dietary Therapy

Summary

Botanicals and herbs have a centuries-old tradition of use by persons with epilepsy, in many cultures around the world. At present, herbal therapies are tried by patients in developing as well as developed countries for control of seizures or adverse effects from antiepileptic drugs (AEDs), or for general health maintenance, usually without the knowledge of physicians who prescribe their AEDs. Well-designed clinical trials of herbal therapies in patients with epilepsy are scarce, and methodological issues prevent any conclusions of their efficacy or safety in this population. Furthermore, some botanicals and herbs may be proconvulsant or may alter AED metabolism. In spite of these limitations, further preclinical evaluation of botanicals and herbs and their constituent compounds using validated scientific methods is warranted based on numerous anecdotal observations of clinical benefit in patients with epilepsy and published reports showing mechanisms of action relevant to epilepsy or anticonvulsant effects in animal models of epilepsy. This review highlights the use of herbal therapies for epilepsy, outlines the role of the U.S. Food and Drug Administration in regulating herbal products, and presents the author’s approach to the scientific assessment of herbal therapies as potential therapies for patients with epilepsy.

Key Words

Epilepsy herbal medicine botanical dietary supplement complementary and alternative therapies huperzine A 

References

  1. 1.
    Brodie MJ. Diagnosing and predicting refractory epilepsy. Acta Neurol Scand Suppl 2005;181: 36–39.CrossRefPubMedGoogle Scholar
  2. 2.
    Meinardi H, Scott RA, Reis R, Sander JW; ILAE Commission on the Developing World. The treatment gap in epilepsy: the current situation and ways forward. Epilepsia 2001;42: 136–149.CrossRefPubMedGoogle Scholar
  3. 3.
    Wahner-Roedler DL, Elkin PL, Vincent A, et al. Use of complementary and alternative medical therapies by patients referred to a fibromyalgia treatment program at a tertiary care center. Mayo Clin Proc 2005;80: 55–60.CrossRefPubMedGoogle Scholar
  4. 4.
    Liow K, Ablah E, Nguyen JC, et al. Pattern and frequency of use of complementary and alternative medicine among patients with epilepsy in the midwestern United States. Epilepsy Behav 2007; 10: 576–582.CrossRefPubMedGoogle Scholar
  5. 5.
    Easterford K, Clough P, Comish S, Lawton L, Duncan S. The use of complementary medicines and alternative practitioners in a cohort of patients with epilepsy. Epilepsy Behav 2005;6: 59–62.CrossRefPubMedGoogle Scholar
  6. 6.
    Peebles CT, McAuley JW, Roach J, Moore JL, Reeves AL. Alternative medicine use by patients with epilepsy. Epilepsy Behav 2000;1: 74–77.CrossRefPubMedGoogle Scholar
  7. 7.
    Sirven JI, Drazkowski JF, Zimmerman RS, Bortz JJ, Shulman DL, Macleish M. Complementary/alternative medicine for epilepsy in Arizona. Neurology 2003;61: 576–577.PubMedGoogle Scholar
  8. 8.
    Rhodes PJ, Small N, Ismail H, Wright JP. The use of biomedicine, complementary and alternative medicine, and ethnomedicine for the treatment of epilepsy among people of South Asian origin in the UK. BMC Complement Altern Med 2008;8: 7.CrossRefPubMedGoogle Scholar
  9. 9.
    Harms SL, Garrard J, Schwinghammer P, Eberly LE, Chang Y, Leppik IE. Ginkgo biloba use in nursing home elderly with epilepsy or seizure disorder. Epilepsia 2006;47: 323–329.CrossRefPubMedGoogle Scholar
  10. 10.
    Kupiec T, Raj V. Fatal seizures due to potential herb-drug interactions with Ginkgo biloba. J Anal Toxicol 2005;29: 755–758.PubMedGoogle Scholar
  11. 11.
    Bressler R. Herb-drug interactions between Ginkgo biloba and prescription medications. Geriatrics 2005;60: 30–33.PubMedGoogle Scholar
  12. 12.
    Elferink JGR. Epilepsy and its treatment in the ancient cultures of America. Epilepsia 1999;40: 1041–1046.CrossRefPubMedGoogle Scholar
  13. 13.
    Kim IJ, Kang JK, Lee SA. Factors contributing to the use of complementary and alternative medicine by people with epilepsy. Epilepsy Behav 2006;8: 620–624.CrossRefPubMedGoogle Scholar
  14. 14.
    Lai CW, Huang X, Lai YHC, Zhang Z, Liu G, Yang MZ. A survey of public awareness, understanding and attitudes toward epilepsy in Henan province, China. Epilepsia 1990;31: 182–187.PubMedGoogle Scholar
  15. 15.
    Danesi MA, Adetunji JB. Use of alternative medicine by patients with epilepsy: a survey of 265 epileptic patients in a developing country. Epilepsia 1994;35: 344–351.CrossRefPubMedGoogle Scholar
  16. 16.
    Vattanajun A, Watanabe H, Tantisira MH, Tantisira B. Isobolographically additive anticonvulsant activity between Centella asiatica’s ethyl acetate fraction and some antiepileptic drugs. J Med Assoc Thai 2005;88 Suppl 3: S131-S140.PubMedGoogle Scholar
  17. 17.
    Tandon M, Prabhakar S, Pandhi P. Pattern of use of complementary/alternative medicine (CAM) in epileptic patients in a tertiary care hospital in India. Pharmacoepidemiol Drug Saf 2002;11: 457–463.CrossRefPubMedGoogle Scholar
  18. 18.
    Saper RB, Kales SN, Paquin J, et al. Heavy metal content of Ayurvedic herbal medicine products. JAMA 2004;292: 2868–2873.CrossRefPubMedGoogle Scholar
  19. 19.
    Huang WF, Wen KC, Hsiao ML. Adulteration by synthetic therapeutic substances of traditional Chinese medicines in Taiwan. J Clin Pharmacol 1997;37: 344–350.PubMedGoogle Scholar
  20. 20.
    Ernst E. Serious psychiatric and neurological adverse effects of herbal medicine: a systematic review. Acta Psychiatr Scand 2003; 108: 83–91.CrossRefPubMedGoogle Scholar
  21. 21.
    Pearl PL, Robbins EL, Bennett HD, Conry JA. Use of complementary and alternative therapies in epilepsy: cause for concern. Arch Neurol 2005;62: 1472–1475.CrossRefPubMedGoogle Scholar
  22. 22.
    Huxtable RJ. The harmful potential of herbal and other plant products. Drug Saf 1990;5 Suppl 1: 126–136.CrossRefPubMedGoogle Scholar
  23. 23.
    Luciano DJ, Spinella M. Herbal treatment of epilepsy: phytotherapy. In: Devinsky O, Schachter SC, Pacia S, editors. Complementary and alternative therapies for epilepsy. New York: Demos Medical Publishing, 2005: 143–155.Google Scholar
  24. 24.
    Gil Campos M, Pérez Navero JL, Ibarra De La Rosa I. Convulsive status secondary to star anise poisoning in a neonate [In Spanish]. An Esp Pediatr 2002;57: 366–368.Google Scholar
  25. 25.
    Johanns ES, van der Kolk LE, van Gemert HM, Sijben AE, Peters PW, de Vries I. An epidemic of epileptic seizures after consumption of herbal tea [In Dutch]. Ned Tijdschr Geneeskd 2002;146: 813–816.PubMedGoogle Scholar
  26. 26.
    Miwa H, Iijima M, Tanaka S, Mizuno Y. Generalized convulsions after consuming a large amount of gingko nuts. Epilepsia 2001; 42: 280–281.PubMedGoogle Scholar
  27. 27.
    Spinella M. Herbal medicines and epilepsy: the potential for benefit and adverse effects. Epilepsy Behav 2001;2: 524–532.CrossRefPubMedGoogle Scholar
  28. 28.
    Sirven JI. Alternative therapies for seizures: promises and dangers. Semin Neurol 2007;27: 325–330.CrossRefPubMedGoogle Scholar
  29. 29.
    Neto MM, Cardeal da Costa JA, Garcia-Cairasco N, Netto JC, Nakagawa B, Dantas M. Intoxication by star fruit (Averrhoa carambola) in 32 uraemic patients: treatment and outcome. Nephrol Dial Transplant 2003;18: 120–125.CrossRefPubMedGoogle Scholar
  30. 30.
    Carolino RO, Beleboni RO, Pizzo AB, et al. Convulsant activity and neurochemical alterations induced by a fraction obtained from fruit Averrhoa carambola (Oxalidaceae: Geraniales). Neurochem Int 2005;46: 523–531.CrossRefPubMedGoogle Scholar
  31. 31.
    Oyungu E, Kioy PG, Patel NB. Proconvulsant effect of khat (Catha edulis) in Sprague dawley rats. J Ethnopharmacol 2009; 121: 476–478.CrossRefPubMedGoogle Scholar
  32. 32.
    Wang Y, Zhou D, Wang B, et al. A kindling model of pharmacoresistant temporal lobe epilepsy in Sprague-Dawley rats induced by Coriaria lactone and its possible mechanism. Epilepsia 2003: 44: 475–488.CrossRefPubMedGoogle Scholar
  33. 33.
    Obach RS. Inhibition of human cytochrome P450 enzymes by constituents of St. John’s wort, an herbal preparation used in the treatment of depression. J Pharmacol Exp Ther 2000;294: 88–95.PubMedGoogle Scholar
  34. 34.
    Delgoda R, Westlake AC. Herbal interactions involving cytochrome P450 enzymes: a mini review. Toxicol Rev 2004;23: 239–249.CrossRefPubMedGoogle Scholar
  35. 35.
    Jain S. Ayurveda: the ancient Indian system of medicine. In: Devinsky O, Schachter SC, Pacia S, editors. Complementary and alternative therapies for epilepsy. New York: Demos Medical Publishing, 2005: 123–128.Google Scholar
  36. 36.
    Ojewole JA. Anticonvulsant property of Sutherlandia frutescens R. BR. (variety Incana E. MEY.) [Fabaceae] shoot aqueous extract. Brain Res Bull 2008;75: 126–132.CrossRefPubMedGoogle Scholar
  37. 37.
    Ojewole JA. Anticonvulsant activity of Hypoxis hemerocallidea Fisch. & C. A. Mey. (Hypoxidaceae) corm (‘African potato’) aqueous extract in mice. Phytother Res 2008;22: 91–96.CrossRefPubMedGoogle Scholar
  38. 38.
    Mahomed IM, Ojewole JA. Anticonvulsant activity of Harpagophytum procumbens DC [Pedaliaceae] secondary root aqueous extract in mice. Brain Res Bull 2006;69: 57–62.CrossRefPubMedGoogle Scholar
  39. 39.
    Chauhau AK, Dobhal MP, Joshi BC. A review of medicinal plants showing anticonvulsant activity. J Ethnopharmacol 1988; 22: 11–23.CrossRefGoogle Scholar
  40. 40.
    Kasture VS, Deshmukh VK, Chopde CT. Anxiolytic and anticonvulsive activity of Sesbania grandiflora leaves in experimental animals. Phytother Res 2002;16: 455–460.CrossRefPubMedGoogle Scholar
  41. 41.
    Kulkarni SK, Akula KK, Dhir A. Effect of Withania somnifera Dunal root extract against pentylenetetrazol seizure threshold in mice: possible involvement of GABAergic system. Indian J Exp Biol 2008;46: 465–469.PubMedGoogle Scholar
  42. 42.
    Lai CW, Lai YH. History of epilepsy in Chinese traditional medicine. Epilepsia 1991: 32: 299–302.CrossRefPubMedGoogle Scholar
  43. 43.
    Schachter SC, Acevedo C, Acevedo KA, et al. Complementary and alternative medical therapies. In: Engel J, Pedley TA, editors. Epilepsy: a comprehensive textbook. 2nd ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins, 2008: 1407–1414.Google Scholar
  44. 44.
    Kim HJ, Moon KD, Oh SY, Kim SP, Lee SR. Ether fraction of methanol extracts of Gastrodia elata, a traditional medicinal herb, protects against kainic acid-induced neuronal damage in the mouse hippocampus. Neurosci Lett 2001: 314: 65–68.CrossRefPubMedGoogle Scholar
  45. 45.
    Hsieh CL, Tang NY, Chiang SY, Hsieh CT, Lin JG. Anticonvulsive and free radical scavenging actions of two herbs, Uncaria rhynchophylla (MIQ) Jack and Gastrodia elata Bl., in kainic acid-treated rats. Life Sci 1999;65: 2071–2082.CrossRefPubMedGoogle Scholar
  46. 46.
    Hsieh CL, Chang CH, Chiang SY, et al. Anticonvulsive and free radical scavenging activities of vanillyl alcohol in ferric chloride-induced epileptic seizures in Sprague-Dawley rats. Life Sci 2000: 67: 1185–1195.CrossRefPubMedGoogle Scholar
  47. 47.
    Chiou LC, Ling JY, Chang CC. Chinese herb constituent β-eudesmol alleviated the electroshock seizures in mice and electrographic seizures in rat hippocampal slices. Neurosci Lett 1997;231: 171–174.CrossRefPubMedGoogle Scholar
  48. 48.
    Hsieh CL, Chen ME, Li TC, et al. Anticonvulsant effect of Uncaria rhynchophylla (Miq) Jack, in rats with kainic acid-induced epileptic seizure. Am J Chin Med 1999: 27: 257–264.CrossRefPubMedGoogle Scholar
  49. 49.
    Minami E, Shibata H, Nunoura Y, Nomoto M, Fukuda T. Efficacy of shitei-to, a traditional Chinese medicine formulation, against convulsions in mice. Am J Chin Med 1999: 27: 107–115.CrossRefPubMedGoogle Scholar
  50. 50.
    Ameri A, Gleitz J, Peters T. Bicuculline-induced epileptiform activity in rat hippocampal slices: suppression by aconitum alkaloids. Planta Med 1997;63: 228–232.CrossRefPubMedGoogle Scholar
  51. 51.
    Sugaya E, Yuyama N, Kajiwara K, et al. Regulation of gene expression by herbal medicines: a new paradigm of gene therapy for multifocal abnormalities of genes. Res Commun Mol Pathol Pharmacol 1999;106: 171–180.PubMedGoogle Scholar
  52. 52.
    Khan R, Krishnakumar A, Paulose CS. Decreased glutamate receptor binding and NMDA R1 gene expression in the hippocampus of pilocarpine induced epileptic rats: neuroprotective role of Bacopa monnieri extract. Epilepsy Behav 2008;12: 54–60.CrossRefPubMedGoogle Scholar
  53. 53.
    Park J, Wei H, Lawhon D, Schachter SC. Herbal formulas in epilepsy: a systematic review. Epilepsia 2005;46 Suppl 8: 215 (abstract).Google Scholar
  54. 54.
    Hijikata Y, Yasuhara A, Yoshida Y, Sento S. Traditional Chinese medicine treatment of epilepsy. J Altern Complement Med 2006; 12: 673–677.CrossRefPubMedGoogle Scholar
  55. 55.
    Salih MA, Mustafa AA. A substance in broad beans (Vicia faba) is protective against experimentally induced convulsions in mice. Epilepsy Behav 2008;12: 25–29.CrossRefPubMedGoogle Scholar
  56. 56.
    Zhang YH, Zhao XY, Chen XQ, Wang Y, Yang HH, Hu GY. Spermidine antagonizes the inhibitory effect of huperzine A on [3H]dizocilpine (MK-801) binding in synaptic membrane of rat cerebral cortex. Neurosci Lett 2002;319: 107–110.CrossRefPubMedGoogle Scholar
  57. 57.
    Zangara A. The psychopharmacology of huperzine A: an alkaloid with cognitive enhancing and neuroprotective properties of interest in the treatment of Alzheimer’s disease. Pharmacol Biochem Behav 2003;75: 675–686.CrossRefPubMedGoogle Scholar
  58. 58.
    White HS, Schachter S, Lee D, Xiaoshen J, Eisenberg D. Anticonvulsant activity of huperzine A, an alkaloid extract of Chinese club moss (Huperzia serrata). Epilepsia 2005;46 Suppl 8: 220 (abstract).Google Scholar
  59. 59.
    Schachter SC, White HS, Murphree LJ, Stables J Huperzine A. In: Bialer M, Johannessen SI, Kupferberg HJ, Levy RH, Perucca E, Tomson T, editors. Progress report on new antiepileptic drugs: a summary of the Eighth Eilat Conference (EILAT VIII). Epilepsy Res 2007;73:10–11.Google Scholar

Copyright information

© The American Society for Experimental NeuroTherapeutics, Inc. 2009

Authors and Affiliations

  1. 1.Department of Neurology, Beth Israel Deaconess Medical CenterHarvard Medical SchoolBoston

Personalised recommendations